Wikipedia. Neutron Capture Therapy of Cancer; n.d. Available from: https://en.wikipedia.org/wiki/Neutron_capture_therapy_of_cancer [Last accessed: January 12, 2023].
2.
MatsumuraA, AsanoT, HiroseK, et al.Initiatives toward clinical boron neutron capture therapy in Japan. Cancer Biother Radiopharm, 2023; 38(3):201–207; doi: 10.1089/cbr.2022.0056
3.
KondoN, MasutaniM, ImamichiS, et al.Strategies for preclinical studies evaluating the biological effects of an accelerator-based boron neutron capture therapy system. Cancer Biother Radiopharm, 2023; 38(3):173–183; doi: 10.1089/cbr.2022.0057
4.
NCI. NCI Workshop on Neutron Capture Therapy (NCT) for Cancer; 2022. Available from: https://dctd.cancer.gov/NewsEvents/20220511_NCI_Workshop.htm [Last accessed: January 12, 2023].
5.
SauerweinWAG, UlčarM.Overview of boron neutron capture therapy in 2022. Cancer Biother Radiopharm, 2023; 38(3):143–147; doi: 10.1089/cbr.2022.0072
6.
PorraL, WendlandL, SeppäläT, et al.From nuclear reactor-based to proton accelerator-based therapy: The Finnish Boron Neutron Capture Therapy Experience. Cancer Biother Radiopharm, 2023; 38(3):184–191; doi: 10.1089/cbr.2022.0059
7.
NomotoT, InoueY, YaoY, et al.Poly(vinyl alcohol) boosting therapeutic potential of p -boronophenylalanine in neutron capture therapy by modulating metabolism. Sci Adv, 2020; 6(4):eaaz1722; doi: 10.1126/sciadv.aaz1722
8.
FukumitsuN, MatsumotoY.Development of an imaging technique for boron neutron capture therapy. Cells, 2021; 10(8):2135; doi: 10.3390/cells10082135
9.
PericoD, di SilvestreD, ImamichiS, et al.Systems biology approach to investigate biomarkers, boron-10 carriers, and mechanisms useful for improving boron neutron capture therapy. Cancer Biother Radiopharm, 2023; 38(3):152–159; doi: 10.1089/cbr.2022.0053
10.
Beck-SickingerAG, BeckerDP, ChepurnaO, et al.New boron delivery agents. Cancer Biother Radiopharm, 2023; 38(3):160–172; doi: 10.1089/cbr.2022.0060
11.
HoSL, YueH, TegafawT, et al.Gadolinium neutron capture therapy (GdNCT) agents from molecular to nano: Current status and perspectives. ACS Omega, 2022; 7(3):2533–2553; doi: 10.1021/acsomega.1c06603
12.
BarthRF, CarpenterDE.Rodent brain tumor models for studies focusing on boron neutron capture therapy. Cancer Biother Radiopharm, 2023; 38(3):148–151; doi: 10.1089/cbr.2022.0041
13.
Monti HughesA, SchwintAE.Animal tumor models for boron neutron capture therapy studies (excluding central nervous system solid tumors). Cancer Biother Radiopharm 2022; doi: 10.1089/cbr.2022.0054
14.
HuN, TanakaH, KakinoR, et al.Evaluation of a treatment planning system developed for clinical boron neutron capture therapy and validation against an independent Monte Carlo dose calculation system. Radiat Oncol, 2021; 16(1):243; doi: 10.1186/s13014-021-01968-2
15.
SauerweinWAG, SanceyL, Hey-HawkinsE, et al.Theranostics in boron neutron capture therapy. Life, 2021; 11(4):330; doi: 10.3390/life11040330
16.
SchulteR.New dosimetry methods for NCT. Cancer Biother Radiopharm, 2023; In Press.
17.
WittigA.Optimal design of future NCT clinical trials. Cancer Biother Radiopharm, 2023; In Press.
18.
SauerweinWAG.Reporting dose in boron neutron capture therapy. Cancer Biother Radiopharm, 2023; 38(3):192–194; doi: 10.1089/cbr.2022.0073
